Star, 27, stuns in ‘ultra-short' mini dress
Clinton had been testing the products for 5 months before BOUF was released for general sale in Priceline. Picture: Instagram/IndyClinton
The working mums got to glam up for the event with a blowdry using the BOUF products before the event. Picture: Supplied
Guests ate a Mexican-style feast and sipped on cocktails. Picture: Supplied
'The nicest part of my transformation is how I feel. Even my nose job didn't give me the same confidence boost that my hair regrowth has. After struggling for so many years, I just feel like myself," Clinton told news.com.au.
Attendees were also gifted the products to take home. Picture: Instagram/EmDavies
The 'proprietary blend of botanicals' in the BOUF products took a team of hair microbiologists in Japan 7 years to perfect. Picture Supplied
Clearly, everyone had a whole lot of fun. Picture: Instagram/IndyClinton
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ABC News
21 minutes ago
- ABC News
Gifted balloon sculpture by Jeff Koons is unveiled in the National Gallery of Australia
The National Gallery of Australia (NGA) in Canberra has received a balloon sculpture that could be the most expensive piece ever gifted to the national collection. The sculpture by American artist Jeff Koons — Balloon Venus Dolni Vestonice (Yellow), 2013–17 — is a nearly three-metre-tall polished stainless steel statue. It is inspired by a small artefact made of mammoth ivory from about 45,000 years ago that depicts fertility and the human body. NGA director Nick Mitzevich did not want to put a price on the piece when asked if it could be worth about $20 million. "The value is really set by the market, and as a gift, we don't really comment on the price," he said. "But Jeff Koons's artworks sell up to that price and beyond … He is the highest selling living artist in the world today. "He makes these extraordinary objects that seduce us in, that pull us in, and it asks us to look a bit closer." He said he believed its true value was in its meaning. "The work, for me, references art history. It references a fertility object from about 45,000 years ago, and I love that he is always thinking about art history," Dr Mitzevich said. "And he gives it a 21st-century approach by turning a fertility object, a Venus, into a balloon sculpture. So, he collides history and the present. The gallery's acquisition is part of a five-piece balloon sculpture series known as Antiquity. The pieces differ in colour, but each took years to bring to life, with the others on show all over the world. In a statement, Jeff Koons said he was "happy" Balloon Venus had been gifted to the national collection so it could be digested by the public. "I always enjoyed working with a metallic surface because it reflects us and affirms us. "Whatever [the viewer is] thinking about, if they're feeling a sense of connection to memory and history, this is the art they're experiencing — and when they leave the room, the art leaves with them." The sculpture was gifted by collectors Steve and Kylie Shelley, who said in a statement: Another major gift to the gallery came earlier this year, with philanthropist Geoff Ainsworth donating Edvard Munch's Man with Horse to the national collection. "In the last six months, we've made two extraordinary acquisitions of artists that have really been influential over the last 150 years," Dr Mitzevich said. He invited people to have their own views on the works.
News.com.au
21 minutes ago
- News.com.au
Assistive tech targets market growth while improving lives
Demand for assistive technologies on the rise with growing global ageing population and awareness of disability inclusion Cochlear one of most high-profile ASX assistive technologies companies with legacy spanning more than 40 years Control Bionics helping thousands around the world communicate and connect in ways once thought impossible With a rising global ageing population and awareness of disability inclusion growing, demand is increasing for technologies that help people maintain independence and improve quality of life. Assistive technologies go beyond medical diagnostics or treatment by directly enabling individuals to hear, see, communicate and perform daily activities they might otherwise struggle to do. And while assistive technology delivers clear social benefits and aligns with ESG goals, it's also targeting a rapidly expanding market. Globally the assistive tech market was valued at ~US$22.9 billion in 2023 and is projected to reach US%36.6 bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.8% throughout the decade. In Australia, the assistive technology sector is projected to expand from ~US$720 million in 2023 to more than US$1.7bn by 2030, driven by demographic shifts such as an ageing population and rising prevalence of long-term disabilities. Australia's substantial healthcare expenditure is also considered a pivotal driver for demand in the Australian disabled and elderly assistive device market. Global pioneer in hearing implant technology From restoring communication for those with severe disabilities to preserving vision and enhancing hearing, Australian companies have a proud history in assistive technologies with ASX blue-chip Cochlear (ASX:COH) one of the most high profile. Cochlear stands as one of the world's foremost innovators in assistive hearing technology with a legacy spanning more than 40 years. Cochlear implants and bone conduction devices are life-changing products, which have enabled hundreds of thousands of people globally across all ages to hear and communicate more effectively. Cochlear CEO and president Dig Howitt told Stockhead the organisation continued to progress new technology and care models, having recently launched the Cochlear Nucleus Nexa System, the world's first and only smart implant system. "The Nucleus Nexa Implant is the outcome of a 20 year investment in R&D and is the first cochlear implant to run its own firmware," he said. Howitt said similar to smartphones, the implant firmware could be updated to enable new features and access future innovations. "Recipients will now have access to a better hearing experience with both implant and sound processor updates," he said. "The Nucleus Nexa System builds upon Cochlear's industry-leading portfolio of electrodes, which are designed to optimise the electrode-neural interface and protect cochlea health and opens the door to even greater hearing potential for patients into the future." Enhancing sound in real-world situations While Cochlear may dominate the implantable hearing device market Brisbane-based Audeara (ASX:AUA) is carving out its own space in personalised listening solutions that sit between consumer audio products and clinical hearing aids. The flagship Audeara headphones and TV bundles the company started with use built-in hearing checks to create tailored sound profiles, ensuring clearer, enhanced listening experiences. Audeara managing director James Fielding told Stockhead the features made the devices valuable for those with mild to moderate hearing loss, or for people using cochlear implants and hearing aids who got an incredible entertainment experience when the sound was tailored to their needs. Building its portfolio Audeara launched Buds into its clinic networks this year. Unlike conventional hearing aids, Buds focus on enhancing the sound in real world situations like a busy cafe while also staying true to their entertainment focus, enhancing calls, TV and music. "We believe assistive technology should enhance the human experience without compromise," Fielding said. "At Audeara, our personalised hearing solutions empower people to connect more deeply with music, conversations and entertainment, regardless of their hearing ability." The technology also supports accessibility through government funding programs including NDIS, DVA and the Hearing Services Program, broadening its reach and affordability. With distribution in 1,500 clinics across Australia and more than 3,000 globally, including partnerships with major networks like Specsavers and Amplifon, Audeara is well positioned to capture growth in a market that's both socially impactful and commercially attractive. "The future of assistive technology is about inclusion, not limitation," Fielding said. "Audeara's mission is to ensure that hearing health solutions are seamlessly integrated into everyday life, combining clinical credibility with consumer-level accessibility." 'Giving communication back for more than two decades' Control Bionics (ASX:CBL) CEO Jeremy Steele describes the assistive technology medical device company as "sitting at the intersection of neuroscience and accessibility". "For more than 20 years, Control Bionics has been at the forefront of assistive technology innovation, helping thousands of people around the world communicate and connect in ways once thought impossible," Steele told Stockhead. Control Bionics has developed the NeuroNode – a wearable, watch-like, wireless non-invasive electromyography (EMG) and spatial sensor device to assist cognitive people with physical disabilities perform everyday functions. He said NeuroNode was globally unique as the only augmentative and alternative communication (AAC) technology of its kind that combined movement and EMG signals into a single platform. "Recognition by the US Centers for Medicare & Medicaid Services, awarding NeuroNode the first HCPCS code for an AAC device in 13 years, validates both the technology and the profound impact it delivers," he said. "We're proud to be a pioneer in the fast-emerging neurotechnology space, empowering people living with conditions like ALS, cerebral palsy and spinal cord injury to reclaim their voice and their independence." Steele said the company's objective was simple but ambitious – to expand global access to the most advanced, intuitive and life-changing assistive technologies available today. "The NeuroNode isn't just a device, it's a lifeline to communication, control and connection," he said. "We believe that every person – regardless of physical ability — deserves a way to engage with the world. "Our team's work over two decades reflects a deep commitment to designing technologies that break through barriers and restore possibility."
News.com.au
21 minutes ago
- News.com.au
Champion jockey Glen Boss pays tribute to semi-retired legendary trainer Lee Freedman
Twenty years after Lee Freedman's famous Melbourne Cup quote, champion jockey Glen Boss revealed he believed the legendary trainer's 'find the smallest child' remark was completely off the cuff. Shortly after the great mare Makybe Diva had won a record third straight Melbourne Cup carrying 58kg at Flemington, Freedman came up with the line that will be forever etched in the history of the race that stops a nation. 'Go out and find the smallest child here because that child might be the only person who lives long enough to see something like this again,' Freedman said at the time. For Boss, the clever comment encapsulated the trainer's razor-sharp wit and intelligence that helped him jag 124 Group 1s and cemented his standing as a household name in Australia. , opting not to renew his trainer's licence for the new racing season. He is now solely the manager of his Gold Coast stable, which has been handed over to his younger brother and Sydney trainer Michael Freedman. Boss chatted to Racenet this week about the profound effect that Lee Freedman and his brothers Anthony, Richard and Michael had on his illustrious career which ended in 2021. Hall of Fame trainer Freedman gave Boss his big break in 1995 on Flying Spur, who the Queenslander rode to victory in the Golden Slipper just a few days after Jim Cassidy's licence had been disqualified due to the 'jockey tapes' scandal. 'Until you sit back and look at his record, you forget how great this bloke was,' Boss said from South Africa, where the retired hoop is holidaying with his family. 'His sense of timing was always good. 'I mean that pivotal moment when the mare (Makybe Diva) won in the Cup in 2005 and he said that line 'go find the smallest child', those sort of things go down in history. 'I don't think he scripted that, I think it came straight out of his mouth. 'I remember seeing Lee around parties and things like that and he's a funny guy with a great sense of humour. 'He's great company and super intelligent to talk to. Not that many people would've got to see the fun side of Lee.' Lee Freedman won five Melbourne Cups, with Boss on board for two of those victories on Makybe Diva in 2004 and 2005, plus four Caulfield Cups, four Golden Slippers and two Cox Plates. 'Having been around him and observed him a fair bit, Lee has an incredible eye for detail which never ceases to amaze me,' said the 55-year-old Boss, who won 90 Group 1s. 'He always knew exactly where his horses were and how to push the button at the right time. 'It'd amaze me how he'd just look at a horse and say 'yep, we're ready now' or he'd say 'nup, we need to do one more thing'. 'He was never set to a pattern with a horse. He'd change his mind on the fly and he had unbelievable instincts.' As the driving force behind the famous Freedman Brothers Incorporated (FBI), Lee played a key role in bringing then-teenage apprentice jockey Damien Oliver from Perth to Melbourne in 1990 when he won the Group 1 Caulfield Guineas on Centro for the powerful stable. Oliver and the Freedmans combined for a superb 24 elite-level victories in the 1990s, including champion stayer Doriemus winning the Melbourne Cup-Caulfield Cup double in 1995. 'They played a big part in getting me over to Melbourne and gave me fantastic opportunities as a young apprentice,' said Oliver, who won an Australian record 129 Group 1s. 'Lee and all the brothers were very ambitious and that sort of shone through to me. 'I was a bit like that anyway but they really brought that side out of me.'
